mortality/aging
• 10% of mice die from glioblastoma multiforme development following intracranial injection of an adenoviral cre unlike similarly treated Col1a1tm1(CAG-EGFR)Char homozygotes that do not develop tumors
|
neoplasm
• following intracranial injection of an adenoviral cre, mice develop glioblastoma multiforme with a greater than 90% tumor-free survival past 30 weeks unlike similarly treated Col1a1tm1(CAG-EGFR)Char homozygotes that do not develop tumors
|
nervous system
• following intracranial injection of an adenoviral cre, mice develop glioblastoma multiforme with a greater than 90% tumor-free survival past 30 weeks unlike similarly treated Col1a1tm1(CAG-EGFR)Char homozygotes that do not develop tumors
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
high grade glioma | DOID:3070 |
OMIM:PS137800 |
J:146494 |